Efficacy / Effect
The drug is administered as an adjunct to diet and exercise therapy to improve glycemic control in adult type 2 diabetic patients who are suitable for the combination administration of gemigliptin and metformin.
* Zemimet SR tablet 25/500 mg, 25/1000 mg, 50/1000 mg:
- Patients who have not had previous diabetes drug treatment, and have difficulty maintaining sufficient glycemic control with monotherapy
- Patients who have difficulty maintaining sufficient glycemic control with metformin monotherpy.
- If combination therapy of metformin and sulfonylurea does not provide sufficient glycemic control, this drug (combination of gemigliptin/metformin) is administered in combination.
- If combination therapy of insulin and metformin does not provide sufficient glycemic control, this drug (combination of gemigliptin/metformin) is administered in combination.
- When replacing the combination therapy of gemiliptin and metformin
* Zemimet SR tablet 50/500 mg :
- Patients who have not had previous diabetes drug treatment, and have difficulty maintaining sufficient glycemic control with monotherapy
- When replacing the combination therapy of gemiliptin and metformin
Active Ingredient and Capacity
Gemigliptin/Metformin: 25/500 mg, 25/1000 mg, 50/500 mg, 50/1000 mg
etc.
Appearance & Packaging Unit
25/500 mg: Light brown oval film-coated tablet
25/1000 mg: Yellow-brown rectangle film-coated tablet
50/500 mg: Orange oval film-coated tablet
50/1000 mg: Brown rectangle film-coating tablet
56 tablets/PTP(14 tablets/PTP x 4)
Storage
In a tight container, store at room temperature (1~30℃)
Advanced Adhesive Products and Their Functions